Iressa Improves Progression-Free Survival in Metastatic Esophageal Cancer
Treatment with Iressa® (gefitinib) slowed disease progression and improved quality of life in patients with metastatic esophageal cancer, according to the results of a phase III trial presented at the...
View ArticleSurgery Improves Survival in Esophageal Cancer
Surgery after chemoradiotherapy—which is the standard of care in advanced esophageal cancer—increased overall and disease-free survival compared with chemoradiotherapy alone, according to the results...
View ArticleSecond-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer
Second-line treatment with docetaxel improves overall survival of patients with advanced esophageal and gastric cancer, according to the results of a study presented at the 2013 Gastrointestinal...
View ArticleClik here to view.
New Online Support Group for People Affected by Gastrointestinal Conditions:...
Are you suffering from a gastrointestinal (GI) tract condition? You are not alone! TheGIConnection is now available for patients, caregivers, and health consumers as an up to date online information...
View ArticleFDA Approves Cyramza™ in Combination With Paclitaxel for Advanced Gastric or...
The U.S. Food and Drug Administration(FDA) has approved Cyramza™ (ramucirumab) for use in combination with paclitaxel for the treatment of patients with advanced gastric or gastroesophageal junction...
View ArticleEsophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung...
Targeted therapy commonly used in lung cancer improves survival of esophageal cancer patients according to clinical trial results recently presented at the National Cancer Research Institute (NCRI)...
View ArticleAMG 337 MET Inhibitor Produces Impressive, Rapid Response in Gastric and...
AMG 337 is a novel small-molecule MET inhibitor that appears to show promise in the treatment of MET-amplified gastroesophageal junction, gastric, and esophageal cancers. MET inhibitors are a class of...
View ArticleNational Esophageal Cancer Awareness Month on CancerConnect
Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of esophageal cancer educational programs for national esophageal cancer awareness month. As the month of April brings...
View ArticleNew Drug Combination Boosts Survival in Advanced Stomach and Esophageal Cancers
Patients whose metastatic stomach or esophageal cancers were driven by a mutated HER2 gene had markedly improved response rates and survival when bevacizumab (Avastin) was added to a standard drug...
View ArticleProton Beam Therapy May Improve Outcomes for Esophageal Cancer
Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. […] The post Proton Beam Therapy May Improve...
View Article
